Zobrazeno 1 - 10
of 117
pro vyhledávání: '"E V Tsyrlina"'
Autor:
V F Semiglazov, V V Semiglazov, V G Ivanov, L M Bershteyn, E V Tsyrlina, E K Zhil'tsova, A S Arzumanov, K Sh Nurgaziev
Publikováno v:
Современная онкология, Vol 3, Iss 1, Pp 23-26 (2001)
Рак молочной железы (РМЖ) является высокочувствительной к лекарственному лечению опухолью. Успехи в терапии этого страдания - отражение
Externí odkaz:
https://doaj.org/article/a5581f1180cf4612bd5238255771cca0
Autor:
V F Semiglazov, E K Zhil'tsova, V V Semiglazov, V G Ivanov, G A Dashyan, A A Klettsel', A A Bozhok, K S Nurgaziev, E E Topuzov, P V Krivorot'ko, E V Tsyrlina, L M Bershteyn
Publikováno v:
Современная онкология, Vol 5, Iss 4, Pp 154-156 (2003)
Аримидекс (анастрозол) является более эффективным , чем тамоксифен или комбинация аримидекса (анастрозол) с тамоксифеном, в неоадъювант
Externí odkaz:
https://doaj.org/article/ec9dec3887e245a2879ec62d1bb70170
Autor:
E. V. Tsyrlina, T. E. Poroshina, D. A. Vasiliev, G. V. Zinoviev, G. I. Gafton, L. M. Berstein
Publikováno v:
Siberian journal of oncology. 21:33-41
Introduction. The incidence and mortality of malignant melanoma have increased steadily over the last decades; therefore, the development of novel diagnostic markers for malignant melanoma is of great importance. The purpose of the study was to asses
Autor:
L. M. Zabegina, N. S. Nikiforova, I. V. Nazarova, M. S. Knyazeva, E. V. Tsyrlina, S. A. Reva, A. K. Nosov, A. M. Malek
Publikováno v:
Cancer Urology. 17:65-75
Background. MicroRNAs (miRNAs) circulating in plasma are promising markers for the diagnosis of malignant tumors, including prostate cancer. However, the existing techniques used for their detection fail to ensure sufficient diagnostic accuracy. One
Publikováno v:
Sibirskij Onkologičeskij Žurnal, Vol 20, Iss 2, Pp 37-45 (2021)
P urpose of the study : to assess whether the determination of the grade of dNA damage in the blood lymphocytes of patients with metastatic melanoma can be a criterion for assessing the effectiveness of therapy. Material and Methods. The grade of dNA
Autor:
L. M. Berstein, E. V. Tsyrlina
Publikováno v:
Neuroscience and Behavioral Physiology. 51:270-278
This review presents basic data on the hypothalamo-hypophyseal system (HHS) and its main components; the role of age (with the focus on aging) is discussed as a factor linked with changes in the state of the HHS and mediating its involvement in “pr
Autor:
A. M. Belyaev, L. M. Berstein, D. A. Vasil’ev, E. V. Kostromina, L. A. Krasil’nikova, P. I. Krzhivitskiy, A. A. Mikhet’ko, A. V. Mishchenko, S. N. Novikov, Z. A. Radzhabova, D. A. Sinyachkina, E. V. Tsyrlina
Publikováno v:
Opuholi Golovy i Šei, Vol 8, Iss 1, Pp 17-23 (2018)
A method for assessing the likelihood of finding a differentiated thyroid cancer based on the use of the Petrov Thyroid Cancer Score (PTCS) is proposed. The individual components of the score are divided into 4 groups in terms of their diagnostic sig
Autor:
R. B. Samsonov, V. S. Burdakov, T. A. Shtam, Z. A. Radzhabova, Y. V. Cheburkin, D. A. Vasilyev, E. V. Tsyrlina, S. E. Titov, M. К. Ivanov, M. V. Filatov, L. M. Berstein, N. N. Kolesnikov, А. V. Malek
Publikováno v:
Opuholi Golovy i Šei, Vol 7, Iss 2, Pp 16-24 (2017)
Introduction. In clinical practice, differential diagnosis of nodular thyroid diseases poses a serious problem which can be solved by development of new, safe, and specific thyroid tumor markers. Small regulatory RNAs (microRNA, miRNA) are a class of
Autor:
R. B. Samsonov, L. M. Berstein, I. M. Kovalenko, E. V. Tsyrlina, G. A. Dashan, A. V. Malek, David Karasik, Ch. . Shochat-Carvalho, D. A. Vasilyev, V. V. Lutynskij
Publikováno v:
Russian Journal of Biotherapy. 15:6-15
Background. Malignant phenotype of cancer cells and metastatic potency of the tumor are determined by genetic factors. In addition, normal biological environment, including the nano-vesicles or exosomes, plays an important role in regulation of the s
Publikováno v:
Voprosy onkologii. 62(2)
Over the few past years there have been passed many significant and positive changes in various fields of oncology due to both the use of achievements, stimulated by previous generations, and the progress of modern technology. This largely concerns e